Agree & Join LinkedIn
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Create your free account or sign in to continue your search
or
New to LinkedIn? Join now
Learn how to balance the needs and interests of different partners in a market access collaboration, and overcome the challenges and risks involved.
Learn how to monitor and manage the risks of price erosion and reference pricing in global markets with these six strategies for market access professionals.
Learn some of the best practices for aligning market access teams across different regions and countries in the pharma and biotech industry.
Learn how to conduct a reimbursement assessment, develop a reimbursement strategy, communicate your value proposition, monitor your reimbursement performance, and…
Learn how to work with health technology assessment (HTA) agencies, who evaluate the impact and value of health technologies, and discover the best practices and…
Learn how to create and maintain an innovative and differentiated organization in biotech with these six steps.
Learn how to collaborate and communicate with RWE and CER stakeholders across sectors and regions.
Learn the best practices for market access digital transformation, from assessing your current state to designing your future state to implementing your roadmap.
Learn how orphan drug manufacturers can collaborate with patient advocacy groups to overcome market access challenges and differentiate their medicines.
Learn how to use cloud computing for health data analytics and insights. Discover the benefits, challenges, and tips of cloud-based solutions for health data…
Learn how collaboration, patient advocacy, innovation, data, and digital health can improve the access and delivery of rare disease therapies.
Learn how to balance the needs and expectations of different payers and patients in market access with these six steps: understand, communicate, engage, adapt…
Learn how to optimize your pricing and reimbursement negotiations across different regions and stakeholders for market access. Discover tips on market landscape…
Learn about the skills and competencies that market access professionals need to engage and advocate for patients in healthcare. Discover how to co-create…
Learn how to optimize your market access and reimbursement strategy by assessing the value proposition of your drug for different payer segments.
Learn how to design and implement a market access launch excellence framework that covers six key steps: vision, plan, execution, monitoring, optimization, and…
Learn how to optimize your market access team structure and capabilities to reach the right customers at the right price and value proposition in the healthcare…
This article explores how patient access schemes can use patient preference data in decision-making, and the benefits and challenges of doing so.
Learn how to assess, identify, prioritize, develop, and monitor your market access evidence gaps and needs for new products with these tips.
Learn how to optimize market access outcomes for biosimilars and generics with effective pricing and reimbursement strategies based on market access principles and…
Learn about the benefits and drawbacks of patient access schemes (PAS) for drug development and innovation, and the key issues to consider for their implementation.
Learn how to incorporate health economics and outcomes research (HEOR) into your pricing strategy and what tools and methods you can use to show the value of your…
Learn about the common issues and risks of tendering and procurement in healthcare, and how to avoid or mitigate them for better value and quality.
Learn the key steps and considerations to create a value-based digital health reimbursement model that aligns incentives and demonstrates value.
Learn how to monitor and manage the risks and uncertainties of patient access schemes (PAS) for new medicines in market access.
Learn how to foster collaboration and innovation in patient access schemes (PAS) across the industry and academia with these best practices and tips.
Learn about the most common career paths and levels for market access professionals, and the skills and qualifications required for each role.
Learn how to collaborate and negotiate with key decision makers and influencers in the health system, such as payers, regulators, providers, and patients.
Learn the main objectives of health economics in market access and how they help you demonstrate value, generate evidence, engage stakeholders, optimize value, and…
Learn how to connect with market access experts and influencers who can help you advance your career, knowledge, and network in the healthcare sector.
Learn how to navigate the complex market access landscape for digital health innovations in different countries. Explore six key factors and strategies for success.
Learn how to follow policy developments, learn from best practices, update skills and knowledge, and seek feedback and collaboration in market access.
Learn key tips and strategies to craft a compelling value proposition and tailor your messages to different stakeholders in the life sciences industry.
Learn some of the best practices for cross-functional collaboration in market access projects, such as defining goals and roles, using common language and…
Learn about the key trends in biotech market access, such as regulation, value, digital, patient, and ESG, and how to adapt to them.
Learn how to lead and mentor a Market Access team or function effectively with these tips and best practices on vision, collaboration, skills, diversity, and…
Learn how to train and coach your team on value proposition and communication skills for market access. Discover how to assess, provide, use, monitor, and support…
Learn how to develop and maintain trust and credibility with your stakeholders in market access using stakeholder mapping and engagement tools.
Learn how to manage and mitigate the risks and challenges of market access in low- and middle-income countries with these key points.
Learn how digital technologies and innovative solutions can help orphan drug developers overcome market access challenges and optimize their outcomes.
Learn how to evaluate your product's value proposition and optimize your pricing and positioning for different market segments.
Learn the key elements of a successful value proposition for rare disease therapies, and how to tailor it to different stakeholder needs and expectations.
Learn how to work with stakeholders to facilitate innovative payment models for drugs that can improve patient outcomes and health system sustainability.
Learn how to create a user-friendly and user-centric digital health solution that delivers value to your users and stakeholders. Follow these tips and best…
Learn how multi-stakeholder collaboration can improve rare disease access and affordability, and explore the benefits, challenges, best practices, and examples.
Learn six steps to design a value-based contract that links payment to outcomes and evidence for a new gene therapy.
Learn how real-world evidence (RWE) can supplement RCTs, fill evidence gaps, support adaptive pathways, enable value-based agreements, foster stakeholder…
Learn how digital health can measure and communicate its impact on health systems and populations in the context of market access. Find tips for creating value…
How to overcome barriers and leverage enablers for digital health adoption
Learn how to align your global and local HTA teams for optimal market access of your health technology. Follow these six tips to navigate the complex HTA landscape.
Learn the best practices for aligning your HTA submissions across different regions and optimizing your market access strategy.
Learn the key elements of market access, and how to apply best practices and frameworks to optimize your outcomes.
Learn how to achieve market access in emerging markets with six steps that can enhance learning and innovation among stakeholders.
Learn how to optimize orphan drug launch and lifecycle management in different markets by addressing regulatory, pricing, patient, and competitive factors.